Publications
44 publications
Clinical research
2 studies
Completed & closed trials (2)
- PINCT04150068A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long-Acting Capsid Inhibitor GS-6207 in Combination With an Optimized Background Regimen in Heavily Treatment Experienced People Living With HIV-1 Infection With Multidrug ResistancePHASE2; PHASE3 · Gilead Sciences, Inc. · IRB STUDY CLOSURE (as of 2025)HIV-1-infection
- PINCT04501952A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of COVID-19 in an Outpatient SettingPHASE3 · Gilead Sciences, Inc. · IRB STUDY CLOSURE (as of 2025)COVID-19